mRNA新冠疫苗接种与接种后21天及12周的视网膜静脉阻塞发生无关。
mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination.
作者信息
Shaia Jacqueline K, Shukla Priya, Jampol Lee, Singh Rishi P
机构信息
Case Western School of Medicine Department of Population and Quantitative Health Sciences, Cleveland, OH, USA.
Center for Ophthalmic Bioinformatics Cleveland Clinic, Cleveland, OH, USA.
出版信息
NPJ Vaccines. 2024 Oct 28;9(1):202. doi: 10.1038/s41541-024-00983-0.
Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.
病例报告推测了2019冠状病毒病（COVID-19）疫苗接种是否可能与视网膜血管阻塞（RVO）有关。具体而言，先前的文献推测在接种疫苗数天至数周后发生视网膜血管阻塞的风险增加。在回顾最近的两项分析后，mRNA COVID-19疫苗接种在接种后3周和12周似乎不会增加视网膜血管阻塞的风险。尽管两项研究设计不同，但mRNA疫苗似乎不会影响视网膜血管阻塞发生的风险。
Zotero 插件